SAM
AVNS

Smartleaf Asset Management’s Avanos Medical AVNS Stock Holding History

Smartleaf Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12
Closed -$136 – 3516
2025
Q4 		$136 Buy
+12
New +$137 ﹤0.01% 3393
2025
Q2 		– Sell
-10
Closed -$139 – 2740
2025
Q1 		$139 Sell
10
-66
-87% -$1.03K ﹤0.01% 2827
2024
Q4 		$1.18K Sell
76
-184
-71% -$3.64K ﹤0.01% 2646
2024
Q3 		$6.18K Buy
260
+12
+5% +$274 ﹤0.01% 2023
2024
Q2 		$4.86K Buy
+248
New +$4.83K ﹤0.01% 1824
2024
Q1 		– Sell
-26
Closed -$591 – 1855
2023
Q4 		$591 Buy
+26
New +$537 ﹤0.01% 1069

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Smartleaf Asset Management's AVNS Position: Q1 2026 in Review

Smartleaf Asset Management sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 12 shares — an estimated $136 sold.

Smartleaf Asset Management first reported a position in AVNS in Q4 2023 and held it in 6 quarters. The position peaked at $6.18K in Q3 2024. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Smartleaf Asset Management reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Smartleaf Asset Management sold 12 Avanos Medical shares in Q1 2026, an estimated $136.
  • Smartleaf Asset Management first reported a position in Avanos Medical in Q4 2023 and held it in 6 quarters.
  • Smartleaf Asset Management's Avanos Medical position peaked at $6.18K in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.